UroGen Pharma (URGN) Prepaid Assets (2016 - 2026)

UroGen Pharma (URGN) has reported Prepaid Assets for 11 consecutive years, with $19.5 million the latest figure, recorded in Q1 2026.

• Quarterly Prepaid Assets rose 50.43% year-over-year to $19.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.5 million (up 50.43% YoY) and the FY2025 annual result came in at $14.7 million, up 65.88% from the prior year.
• Prepaid Assets improved to $19.5 million in Q1 2026 per URGN's latest filing, from $14.7 million in the prior quarter.
• Over the last five years, Prepaid Assets for URGN reached as high as $19.5 million in Q1 2026 and fell as low as $8.8 million in Q4 2024.
• A 5-year average of $12.3 million and a median of $12.1 million in 2025 frame the typical range for Prepaid Assets.
• Annual changes were most pronounced in 2022 — Prepaid Assets surged 96.55% — and 2024, when it decreased 13.97%.
• Year by year, Prepaid Assets stood at $11.1 million in 2022, then slipped by 7.39% to $10.3 million in 2023, then retreated by 13.97% to $8.8 million in 2024, then surged by 65.88% to $14.7 million in 2025, then surged by 33.11% to $19.5 million in 2026.
• According to Business Quant data, Prepaid Assets over the past three periods registered $19.5 million, $14.7 million, and $12.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.